Semnur Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Semnur Pharmaceuticals Ownership

Who owns Semnur Pharmaceuticals?

Semnur Pharmaceuticals is owned by Sorrento Therapeutics. It was acquired on August 15, 2016.

Semnur Pharmaceuticals Business Overview

Where is Semnur Pharmaceuticals headquartered?

Semnur Pharmaceuticals is headquartered in Los Altos, California.

What sector is Semnur Pharmaceuticals in?

Semnur Pharmaceuticals is a life science company.

When was Semnur Pharmaceuticals founded?

Semnur Pharmaceuticals was founded in 2013.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.

Semnur Pharmaceuticals, Inc.

4970 El Camino Real Suite 205,
Los Altos, California 94022
United States,
(888) 315-8706

Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and commercial development of innovative products that meet the needs of pain management practitioners and their patients. Semnur's primary focus lies in the development of non-opioid products for meeting the needs of underserved patients with back pain. Semnur believes that the therapeutic advantages of their product and technology will improve products' efficacy and safety making a substantial improvement in the treatment of back pain.


 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.